All Psyched Up: A Current List Of Psychedelics Stocks To Watch
When it comes to psychedelics, today’s article notes that “While this industry is still in its early stages, the promising potential of psychedelic medicine drug…
stock market
2 Former Wall Street Pros Share Their 5 Innovative Stocks To Buy
At the recent Global Financial Summit, two former Wall Street professionals shared their picks for innovative stocks to buy for the opportunity to profit from…
When It Comes To These 2 Biopharma Stocks’ Near-Term Gains, Analysts Are Seeing (More Than) Double!
Today’s article highlights two clinical-stage biopharmaceutical stocks that analysts expect to more than double in the coming months — one engaged in discovering and developing…
Key Events – And Potential Catalysts – For Biotech Stocks This Week
After a week that saw mostly strong earnings reports from big pharma companies, an Alzheimer’s conference that moved stocks, and a slew of IPOs of…
These 19 “Moaty” Small-Caps Are High-Quality & Undervalued
Smaller-cap companies have had a good 12 months, and the author of today’s article notes that “the return picture over the trailing three-year period suggests…
Will August Bring FDA Approvals For These Biotech Stocks?
With just a few days remaining in July, the FDA has approved four novel drugs this month, including a treatment for a parasitic “sleeping sickness”…
Already Experiencing Great Runs, These 3 Drug Makers Could Explode Higher
“All of these companies are working on new drugs that could be worth billions, and successes with them would push their stock prices through the…
Focus In The Biotech Sector Could Soon Turn To These Therapeutic Areas And Companies
While vaccine makers have gotten most of the attention in the biotech sector over the past year, the author of today’s article advises that other…
Why Synthetic Biology Could Be An Internet-Level Investment Opportunity – And How To Play It
“This is what it might have been like 25 years ago if some guy had walked up to you and said the internet was going…
Biotech Buys: 2 Top Picks Under $10
As a result of the pandemic, investors have likely become familiar with a number of biotech names over the past year and a half that…